title: Pathological and morphometric assessment of testicular parameters in patients with metastatic prostate cancer following treatment with either the antiandrogen Casodex (ZM176,334) or bilateral orchidectomy.
abstract: Casodex is an orally active non-steroidal antiandrogen that is highly selective for androgen receptors in animals and man. It is indicated for the non-surgical treatment of advanced prostate cancer in man. The present open controlled study in 13 Casodex-treated and 21 orchidectomy-alone (control) patients addressed the hypothesis that chronic administration of antiandrogens will result in Leydig cell hyperplasia as a result of feedback inhibition of the pituitary resulting in increased luteinising hormone (LH) stimulation of Leydig cells. Although Casodex has been shown to produce a moderate rise in circulating plasma testosterone concentration on chronic treatment in prostate cancer patients, a controlled histopathological and morphometric assessment of the testis following orchidectomy in relapsed Casodex patients showed no effect on Leydig cell populations compared with an orchidectomy alone (control) group. No evidence for induction of Leydig cell hypertrophy or hyperplasia as a result of chronic oral administration of 50 mg Casodex daily was obtained in this study.
authors.affiliation: Zeneca Pharmaceuticals, Macclesfield, Cheshire, England.
authors.forename: H B
authors.initials: HB
authors.lastname: Jones
authors.forename: G R
authors.initials: GR
authors.lastname: Betton
authors.forename: A L
authors.initials: AL
authors.lastname: Bowdler
authors.forename: R L
authors.initials: RL
authors.lastname: McFarquhar
authors.forename: B J
authors.initials: BJ
authors.lastname: Middleton
authors.forename: G
authors.initials: G
authors.lastname: Lunglmayr
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use*; D000813:Anilides / Q000627:therapeutic use*; D002452:Cell Count / Q000187:drug effects; D006801:Humans; D007985:Leydig Cells / Q000187:drug effects / Q000473:pathology; D008297:Male; D009570:Nitriles; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000473:pathology / Q000556:secondary / Q000628:therapy*; D012671:Seminiferous Tubules / Q000187:drug effects / Q000473:pathology; D013737:Testis / Q000473:pathology*; D014105:Tosyl Compounds
chemical_list: D000726:Androgen Antagonists; D000813:Anilides; D009570:Nitriles; D014105:Tosyl Compounds; C053541:bicalutamide